Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

by Gao, Shugeng , Reck, Martin , Ostoros, Gyula , Taube, Janis M. , Galffy, Gabriella , Garbaos, Gabriel , Biswas, Bivas , Antonuzzo, Lorenzo , Hochmair, Maximilian , Kuroda, Hiroaki , Fouad, Tamer M. , Winder, Thomas , Harpole, David , Spira, Alexander , You, Jian , Tran, Tho V. , Doherty, Gary J. , Mann, Helen , Le, Ha T. , Akamatsu, Hiroaki , Crawford, Jeffrey , Heymach, John V. , Mitsudomi, Tetsuya , Papai-Szekely, Zsolt , Lee, Kang-Yun , Zukov, Ruslan , Aperghis, Mike

in Adjuvants, Immunologic - therapeutic use / Administration, Intravenous / Antineoplastic Agents, Immunological - administration & dosage / Antineoplastic Agents, Immunological - therapeutic use / Antineoplastic Combined Chemotherapy Protocols - administration & dosage / Antineoplastic Combined Chemotherapy Protocols - adverse effects / Antineoplastic Combined Chemotherapy Protocols - therapeutic use / Apoptosis / B7-H1 Antigen - administration & dosage / B7-H1 Antigen - therapeutic use / Cancer therapies / Carcinoma, Non-Small-Cell Lung - drug therapy / Carcinoma, Non-Small-Cell Lung - pathology / Carcinoma, Non-Small-Cell Lung - surgery / Chemotherapy / Clinical medicine / Clinical practice guidelines / Combined Modality Therapy / Critical Care / Critical Care General / Death / Hematology / Humans / Immunotherapy / Lung Cancer / Lung Neoplasms - drug therapy / Lung Neoplasms - pathology / Lung Neoplasms - surgery / Lymphatic system / Medical screening / Monoclonal antibodies / Neoplasm Recurrence, Local - drug therapy / Non-small cell lung carcinoma / Oncology / PD-L1 protein / Placebos / Pulmonary / Radiation therapy / Small cell lung carcinoma / Statistical analysis / Surgery / Surgery General / Targeted cancer therapy / Treatments in Oncology / Tumors

2023

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

2023

Confirm

Do you wish to request the book?

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

2023

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

Gao, Shugeng,

Reck, Martin,

Ostoros, Gyula,

Taube, Janis M.,

Galffy, Gabriella,

Garbaos, Gabriel,

Biswas, Bivas,

Antonuzzo, Lorenzo,

Hochmair, Maximilian,

Kuroda, Hiroaki,

Fouad, Tamer M.,

Winder, Thomas,

Harpole, David,

Spira, Alexander,

You, Jian,

Tran, Tho V.,

Doherty, Gary J.,

Mann, Helen,

Le, Ha T.,

Akamatsu, Hiroaki,

Crawford, Jeffrey,

Heymach, John V.,

Mitsudomi, Tetsuya,

Papai-Szekely, Zsolt,

Lee, Kang-Yun,

Zukov, Ruslan,

Aperghis, Mike

2023

Overview

Patients with resectable non–small-cell lung cancer had a greater response and longer event-free survival with preoperative durvalumab plus chemotherapy and adjuvant durvalumab than with chemotherapy alone.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Adjuvants, Immunologic - therapeutic use

/ Administration, Intravenous

/ Antineoplastic Agents, Immunological - administration & dosage

/ Antineoplastic Agents, Immunological - therapeutic use

/ Antineoplastic Combined Chemotherapy Protocols - administration & dosage

/ Antineoplastic Combined Chemotherapy Protocols - adverse effects

/ Antineoplastic Combined Chemotherapy Protocols - therapeutic use